Karlinski Andrew C Merck & Co., Inc. Transaction History

Karlinski Andrew C

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $4,311 - $4,842	-51 Reduced 5.75%	836 $72,000
Q2 2022 Aug 15, 2022	SELL	$83.49 - $94.64 $584 - $662	-7 Reduced 0.78%	887 $81,000
Q1 2022 May 13, 2022	BUY	$73.51 - $82.4 $3,234 - $3,625	44 Added 5.18%	894 $73,000
Q4 2021 Mar 09, 2022	BUY	$72.28 - $90.54 $61,438 - $76,959	850 New	850 $1.14 Million

3,829

1.87B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Karlinski Andrew C, based on Form 13F filings with the SEC.

Stay updated on Karlinski Andrew C with notifications on news.